GLP-1 medications have been used in clinical medicine to treat type 2 diabetes since 2005 [1]
#Hypertension #FDAApproval #Cardiology #PrecisionMedicine #MedicalEducation #Pharma #ClinicalTrials #CardioRenal #Animedix #ResistantHypertension To view or add a comment, sign in This week, the FDA approved Baxfendy (baxdrostat) the first aldosterone synthase inhibitor for uncontrolled or treatment-resistant hypertension
Discussion: The results showed that glutathione could effectively treat the liver lipid metabolism disorder of bullfrogs, promote the growth and development of bullfrogs, repair the liver function, reduce the inflammation, and promote the healthy and green development of bullfrog industry
Circ Res 93:354363 Shi F, Wang YC, Zhao TZ, Zhang S, Du TY, Yang CB, Li YH, Sun XQ (2012) Effects of simulated microgravity on human umbilical vein endothelial cell angiogenesis and role of the PI3K-Akt-eNOS signal pathway
We know that these drugs not only lead to weight loss, but also provide some protection against diabetes, heart, kidney and liver disease